Global Intranasal Drug and Vaccine Delivery Devices Market Research Report 2024(Status and Outlook)
Report Overview:
Delivery devices for intranasal drugs and vaccines
The Global Intranasal Drug and Vaccine Delivery Devices Market Size was estimated at USD 214.46 million in 2023 and is projected to reach USD 287.40 million by 2029, exhibiting a CAGR of 5.00% during the forecast period.
This report provides a deep insight into the global Intranasal Drug and Vaccine Delivery Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intranasal Drug and Vaccine Delivery Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intranasal Drug and Vaccine Delivery Devices market in any manner.
Global Intranasal Drug and Vaccine Delivery Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceuticals
GlaxoSmithKline
Teleflex
Intersect
Aptar Pharma
3M
OptiNose
UCB
Bespak
Market Segmentation (by Type)
Powder Conveyor
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Other
Market Segmentation (by Application)
Respiratory Diseases
Nervous System Disease
Vaccination
Pain Department
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intranasal Drug and Vaccine Delivery Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Delivery devices for intranasal drugs and vaccines
The Global Intranasal Drug and Vaccine Delivery Devices Market Size was estimated at USD 214.46 million in 2023 and is projected to reach USD 287.40 million by 2029, exhibiting a CAGR of 5.00% during the forecast period.
This report provides a deep insight into the global Intranasal Drug and Vaccine Delivery Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intranasal Drug and Vaccine Delivery Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intranasal Drug and Vaccine Delivery Devices market in any manner.
Global Intranasal Drug and Vaccine Delivery Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceuticals
GlaxoSmithKline
Teleflex
Intersect
Aptar Pharma
3M
OptiNose
UCB
Bespak
Market Segmentation (by Type)
Powder Conveyor
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Other
Market Segmentation (by Application)
Respiratory Diseases
Nervous System Disease
Vaccination
Pain Department
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Intranasal Drug and Vaccine Delivery Devices Market
- Overview of the regional outlook of the Intranasal Drug and Vaccine Delivery Devices Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intranasal Drug and Vaccine Delivery Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Intranasal Drug and Vaccine Delivery Devices
1.2 Key Market Segments
1.2.1 Intranasal Drug and Vaccine Delivery Devices Segment by Type
1.2.2 Intranasal Drug and Vaccine Delivery Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Manufacturers (2019-2024)
3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Intranasal Drug and Vaccine Delivery Devices Sales Sites, Area Served, Product Type
3.6 Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation and Trends
3.6.1 Intranasal Drug and Vaccine Delivery Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Intranasal Drug and Vaccine Delivery Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2019-2024)
6.3 Global Intranasal Drug and Vaccine Delivery Devices Market Size Market Share by Type (2019-2024)
6.4 Global Intranasal Drug and Vaccine Delivery Devices Price by Type (2019-2024)
7 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intranasal Drug and Vaccine Delivery Devices Market Sales by Application (2019-2024)
7.3 Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Intranasal Drug and Vaccine Delivery Devices Sales Growth Rate by Application (2019-2024)
8 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Intranasal Drug and Vaccine Delivery Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Intranasal Drug and Vaccine Delivery Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva Pharmaceuticals
9.1.1 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Basic Information
9.1.2 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Overview
9.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.1.4 Teva Pharmaceuticals Business Overview
9.1.5 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
9.1.6 Teva Pharmaceuticals Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Basic Information
9.2.2 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Overview
9.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Teleflex
9.3.1 Teleflex Intranasal Drug and Vaccine Delivery Devices Basic Information
9.3.2 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Overview
9.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
9.3.5 Teleflex Business Overview
9.3.6 Teleflex Recent Developments
9.4 Intersect
9.4.1 Intersect Intranasal Drug and Vaccine Delivery Devices Basic Information
9.4.2 Intersect Intranasal Drug and Vaccine Delivery Devices Product Overview
9.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.4.4 Intersect Business Overview
9.4.5 Intersect Recent Developments
9.5 Aptar Pharma
9.5.1 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Basic Information
9.5.2 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Overview
9.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.5.4 Aptar Pharma Business Overview
9.5.5 Aptar Pharma Recent Developments
9.6 3M
9.6.1 3M Intranasal Drug and Vaccine Delivery Devices Basic Information
9.6.2 3M Intranasal Drug and Vaccine Delivery Devices Product Overview
9.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.6.4 3M Business Overview
9.6.5 3M Recent Developments
9.7 OptiNose
9.7.1 OptiNose Intranasal Drug and Vaccine Delivery Devices Basic Information
9.7.2 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Overview
9.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.7.4 OptiNose Business Overview
9.7.5 OptiNose Recent Developments
9.8 UCB
9.8.1 UCB Intranasal Drug and Vaccine Delivery Devices Basic Information
9.8.2 UCB Intranasal Drug and Vaccine Delivery Devices Product Overview
9.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.8.4 UCB Business Overview
9.8.5 UCB Recent Developments
9.9 Bespak
9.9.1 Bespak Intranasal Drug and Vaccine Delivery Devices Basic Information
9.9.2 Bespak Intranasal Drug and Vaccine Delivery Devices Product Overview
9.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.9.4 Bespak Business Overview
9.9.5 Bespak Recent Developments
10 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET FORECAST BY REGION
10.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast
10.2 Global Intranasal Drug and Vaccine Delivery Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country
10.2.3 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Region
10.2.4 South America Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Intranasal Drug and Vaccine Delivery Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Intranasal Drug and Vaccine Delivery Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Intranasal Drug and Vaccine Delivery Devices by Type (2025-2030)
11.1.2 Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Intranasal Drug and Vaccine Delivery Devices by Type (2025-2030)
11.2 Global Intranasal Drug and Vaccine Delivery Devices Market Forecast by Application (2025-2030)
11.2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) Forecast by Application
11.2.2 Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Intranasal Drug and Vaccine Delivery Devices
1.2 Key Market Segments
1.2.1 Intranasal Drug and Vaccine Delivery Devices Segment by Type
1.2.2 Intranasal Drug and Vaccine Delivery Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Manufacturers (2019-2024)
3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Intranasal Drug and Vaccine Delivery Devices Sales Sites, Area Served, Product Type
3.6 Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation and Trends
3.6.1 Intranasal Drug and Vaccine Delivery Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Intranasal Drug and Vaccine Delivery Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2019-2024)
6.3 Global Intranasal Drug and Vaccine Delivery Devices Market Size Market Share by Type (2019-2024)
6.4 Global Intranasal Drug and Vaccine Delivery Devices Price by Type (2019-2024)
7 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intranasal Drug and Vaccine Delivery Devices Market Sales by Application (2019-2024)
7.3 Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Intranasal Drug and Vaccine Delivery Devices Sales Growth Rate by Application (2019-2024)
8 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Intranasal Drug and Vaccine Delivery Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Intranasal Drug and Vaccine Delivery Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva Pharmaceuticals
9.1.1 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Basic Information
9.1.2 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Overview
9.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.1.4 Teva Pharmaceuticals Business Overview
9.1.5 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
9.1.6 Teva Pharmaceuticals Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Basic Information
9.2.2 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Overview
9.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Teleflex
9.3.1 Teleflex Intranasal Drug and Vaccine Delivery Devices Basic Information
9.3.2 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Overview
9.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
9.3.5 Teleflex Business Overview
9.3.6 Teleflex Recent Developments
9.4 Intersect
9.4.1 Intersect Intranasal Drug and Vaccine Delivery Devices Basic Information
9.4.2 Intersect Intranasal Drug and Vaccine Delivery Devices Product Overview
9.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.4.4 Intersect Business Overview
9.4.5 Intersect Recent Developments
9.5 Aptar Pharma
9.5.1 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Basic Information
9.5.2 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Overview
9.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.5.4 Aptar Pharma Business Overview
9.5.5 Aptar Pharma Recent Developments
9.6 3M
9.6.1 3M Intranasal Drug and Vaccine Delivery Devices Basic Information
9.6.2 3M Intranasal Drug and Vaccine Delivery Devices Product Overview
9.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.6.4 3M Business Overview
9.6.5 3M Recent Developments
9.7 OptiNose
9.7.1 OptiNose Intranasal Drug and Vaccine Delivery Devices Basic Information
9.7.2 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Overview
9.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.7.4 OptiNose Business Overview
9.7.5 OptiNose Recent Developments
9.8 UCB
9.8.1 UCB Intranasal Drug and Vaccine Delivery Devices Basic Information
9.8.2 UCB Intranasal Drug and Vaccine Delivery Devices Product Overview
9.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.8.4 UCB Business Overview
9.8.5 UCB Recent Developments
9.9 Bespak
9.9.1 Bespak Intranasal Drug and Vaccine Delivery Devices Basic Information
9.9.2 Bespak Intranasal Drug and Vaccine Delivery Devices Product Overview
9.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product Market Performance
9.9.4 Bespak Business Overview
9.9.5 Bespak Recent Developments
10 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET FORECAST BY REGION
10.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast
10.2 Global Intranasal Drug and Vaccine Delivery Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country
10.2.3 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Region
10.2.4 South America Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Intranasal Drug and Vaccine Delivery Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Intranasal Drug and Vaccine Delivery Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Intranasal Drug and Vaccine Delivery Devices by Type (2025-2030)
11.1.2 Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Intranasal Drug and Vaccine Delivery Devices by Type (2025-2030)
11.2 Global Intranasal Drug and Vaccine Delivery Devices Market Forecast by Application (2025-2030)
11.2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) Forecast by Application
11.2.2 Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Intranasal Drug and Vaccine Delivery Devices Market Size Comparison by Region (M USD)
Table 5. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Intranasal Drug and Vaccine Delivery Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug and Vaccine Delivery Devices as of 2022)
Table 10. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Intranasal Drug and Vaccine Delivery Devices Sales Sites and Area Served
Table 12. Manufacturers Intranasal Drug and Vaccine Delivery Devices Product Type
Table 13. Global Intranasal Drug and Vaccine Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Intranasal Drug and Vaccine Delivery Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intranasal Drug and Vaccine Delivery Devices Market Challenges
Table 22. Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (K Units)
Table 23. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Type (M USD)
Table 24. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2019-2024)
Table 26. Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Intranasal Drug and Vaccine Delivery Devices Market Size Share by Type (2019-2024)
Table 28. Global Intranasal Drug and Vaccine Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application
Table 30. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Application
Table 31. Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2019-2024)
Table 33. Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application (2019-2024)
Table 35. Global Intranasal Drug and Vaccine Delivery Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2019-2024)
Table 38. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 43. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 44. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 45. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Teva Pharmaceuticals Business Overview
Table 47. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
Table 48. Teva Pharmaceuticals Recent Developments
Table 49. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 50. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 51. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Teleflex Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 56. Teleflex Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 57. Teleflex Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Teleflex Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
Table 59. Teleflex Business Overview
Table 60. Teleflex Recent Developments
Table 61. Intersect Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 62. Intersect Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 63. Intersect Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Intersect Business Overview
Table 65. Intersect Recent Developments
Table 66. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 67. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 68. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Aptar Pharma Business Overview
Table 70. Aptar Pharma Recent Developments
Table 71. 3M Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 72. 3M Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 73. 3M Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. 3M Business Overview
Table 75. 3M Recent Developments
Table 76. OptiNose Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 77. OptiNose Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 78. OptiNose Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. OptiNose Business Overview
Table 80. OptiNose Recent Developments
Table 81. UCB Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 82. UCB Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 83. UCB Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. UCB Business Overview
Table 85. UCB Recent Developments
Table 86. Bespak Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 87. Bespak Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 88. Bespak Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bespak Business Overview
Table 90. Bespak Recent Developments
Table 91. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Intranasal Drug and Vaccine Delivery Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Intranasal Drug and Vaccine Delivery Devices Market Size Comparison by Region (M USD)
Table 5. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Intranasal Drug and Vaccine Delivery Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug and Vaccine Delivery Devices as of 2022)
Table 10. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Intranasal Drug and Vaccine Delivery Devices Sales Sites and Area Served
Table 12. Manufacturers Intranasal Drug and Vaccine Delivery Devices Product Type
Table 13. Global Intranasal Drug and Vaccine Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Intranasal Drug and Vaccine Delivery Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intranasal Drug and Vaccine Delivery Devices Market Challenges
Table 22. Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (K Units)
Table 23. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Type (M USD)
Table 24. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2019-2024)
Table 26. Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Intranasal Drug and Vaccine Delivery Devices Market Size Share by Type (2019-2024)
Table 28. Global Intranasal Drug and Vaccine Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application
Table 30. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Application
Table 31. Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2019-2024)
Table 33. Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application (2019-2024)
Table 35. Global Intranasal Drug and Vaccine Delivery Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2019-2024)
Table 38. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 43. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 44. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 45. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Teva Pharmaceuticals Business Overview
Table 47. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
Table 48. Teva Pharmaceuticals Recent Developments
Table 49. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 50. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 51. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Teleflex Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 56. Teleflex Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 57. Teleflex Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Teleflex Intranasal Drug and Vaccine Delivery Devices SWOT Analysis
Table 59. Teleflex Business Overview
Table 60. Teleflex Recent Developments
Table 61. Intersect Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 62. Intersect Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 63. Intersect Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Intersect Business Overview
Table 65. Intersect Recent Developments
Table 66. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 67. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 68. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Aptar Pharma Business Overview
Table 70. Aptar Pharma Recent Developments
Table 71. 3M Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 72. 3M Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 73. 3M Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. 3M Business Overview
Table 75. 3M Recent Developments
Table 76. OptiNose Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 77. OptiNose Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 78. OptiNose Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. OptiNose Business Overview
Table 80. OptiNose Recent Developments
Table 81. UCB Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 82. UCB Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 83. UCB Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. UCB Business Overview
Table 85. UCB Recent Developments
Table 86. Bespak Intranasal Drug and Vaccine Delivery Devices Basic Information
Table 87. Bespak Intranasal Drug and Vaccine Delivery Devices Product Overview
Table 88. Bespak Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bespak Business Overview
Table 90. Bespak Recent Developments
Table 91. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Intranasal Drug and Vaccine Delivery Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Intranasal Drug and Vaccine Delivery Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD), 2019-2030
Figure 5. Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) (2019-2030)
Figure 6. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intranasal Drug and Vaccine Delivery Devices Market Size by Country (M USD)
Figure 11. Intranasal Drug and Vaccine Delivery Devices Sales Share by Manufacturers in 2023
Figure 12. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers in 2023
Figure 13. Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Intranasal Drug and Vaccine Delivery Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Type
Figure 18. Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2019-2024)
Figure 19. Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type in 2023
Figure 20. Market Size Share of Intranasal Drug and Vaccine Delivery Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Intranasal Drug and Vaccine Delivery Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application
Figure 24. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application in 2023
Figure 26. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application (2019-2024)
Figure 27. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application in 2023
Figure 28. Global Intranasal Drug and Vaccine Delivery Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country in 2023
Figure 32. U.S. Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Intranasal Drug and Vaccine Delivery Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Intranasal Drug and Vaccine Delivery Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country in 2023
Figure 37. Germany Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region in 2023
Figure 44. China Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (K Units)
Figure 50. South America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country in 2023
Figure 51. Brazil Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Intranasal Drug and Vaccine Delivery Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Intranasal Drug and Vaccine Delivery Devices Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Intranasal Drug and Vaccine Delivery Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD), 2019-2030
Figure 5. Global Intranasal Drug and Vaccine Delivery Devices Market Size (M USD) (2019-2030)
Figure 6. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intranasal Drug and Vaccine Delivery Devices Market Size by Country (M USD)
Figure 11. Intranasal Drug and Vaccine Delivery Devices Sales Share by Manufacturers in 2023
Figure 12. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers in 2023
Figure 13. Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Intranasal Drug and Vaccine Delivery Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Type
Figure 18. Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2019-2024)
Figure 19. Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type in 2023
Figure 20. Market Size Share of Intranasal Drug and Vaccine Delivery Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Intranasal Drug and Vaccine Delivery Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application
Figure 24. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application in 2023
Figure 26. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application (2019-2024)
Figure 27. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application in 2023
Figure 28. Global Intranasal Drug and Vaccine Delivery Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country in 2023
Figure 32. U.S. Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Intranasal Drug and Vaccine Delivery Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Intranasal Drug and Vaccine Delivery Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country in 2023
Figure 37. Germany Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region in 2023
Figure 44. China Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (K Units)
Figure 50. South America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country in 2023
Figure 51. Brazil Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Intranasal Drug and Vaccine Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Intranasal Drug and Vaccine Delivery Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Intranasal Drug and Vaccine Delivery Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Intranasal Drug and Vaccine Delivery Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Intranasal Drug and Vaccine Delivery Devices Market Share Forecast by Application (2025-2030)
